实用医学杂志 ›› 2021, Vol. 37 ›› Issue (19): 2447-2457.doi: 10.3969/j.issn.1006⁃5725.2021.19.003

• 基础研究 • 上一篇    下一篇

内含子源性长链非编码RNA SOS1⁃IT1 肝癌细胞的调控

付楠楠1 刘蕊2 刘涛2   

  1. 1 天津市儿童医院(天津大学儿童医院)消化科(天津 300134):2 天津市第一中心医院国家卫生健康委员会 危重病急救医学重点实验室(天津 300192)

  • 出版日期:2021-10-10 发布日期:2021-10-10
  • 通讯作者: 刘涛 E⁃mail:liutao@nankai.edu.cn
  • 基金资助:
    国家自然科学基金项目(编号:81402322);天津市第一中心医院科技基金项目(编号:2020CM01)

Regulation of hepatocellular carcinoma cells by long non⁃coding RNA SOS1⁃IT1

FU Nannan*,LIU Rui, LIU Tao.   

  1. Gastroenterology Department,Tianjin Children′s Hospital,Tianjin 300134,China

  • Online:2021-10-10 Published:2021-10-10
  • Contact: LIU Tao E⁃mail:liutao@nankai.edu.cn

摘要:

目的 探寻内含子来源的长链非编码 RNA(lncRNA)SOS1⁃IT1 对肝癌细胞的影响及分子机制。方法 用人肝癌细胞系 QGY⁃7703 作为细胞模型,CCK⁃8 实验检测细胞活性,EdU 实验检测细胞DNA复制活性。生物信息学预测RNA序列中的 miR⁃124 潜在结合位点(MRE)。用真核表达质粒 pcDNA3.1(+ 作为 SOS1⁃IT1及其MRE,以及 miR⁃124 的过表达载体。将MRE克隆插入增强型绿色荧光蛋白(EGFP)的编码区下游,构建荧光报告基因质粒。荧光报告基因实验检测 miR⁃124 MRE序列的特异性结合和调控。结果 在人肝癌 QGY⁃7703 细胞系中,过表达 lncRNA SOS1⁃IT1 能够增强细胞的活性[(1.184 ± 0.114 vs.(0.928 ± 0.104),P < 0.05]并加速DNA复制[(0.625 ± 0.013)vs.(0.206 ± 0.016),P < 0.05],抑制SOS1⁃IT1 则降低细胞活性[(0.648 ± 0.062)vs.(0.870±0.091),P < 0.05]并减缓 DNA复制[(0.126 ± 0.022)vs.(0.271 ± 0.033),P < 0.05]。生物信息学预测发现,SOS1 mRNA SOS1⁃IT1 分别包含 3 个和 1个潜在的 miR⁃124 MRE。荧光报告基因实验确定,SOS1 mRNA 的前 2 MRE,以及 SOS1⁃IT1 MRE 均为 miR⁃124 的有效结合位点。用包含 SOS1⁃MRE 的荧光报告基因质粒转染 QGY⁃7703 细胞,同时表达 SOS1⁃IT1 MRE 能够增强荧光强度[(3.68 ± 0.315)vs.(2.71 ± 0.180),P < 0.05]。进一步过表达 miR⁃124 后,荧光强度发生回落 [(1.09 ± 0.143)vs.(4.04 ± 0.079),P < 0.05]。若将任意一个MRE序列突变,荧光强度不再发生变化[(2.57 ± 0.244)vs.(2.71 ± 0.180);(2.66 ± 0.200)vs.(2.88 ± 0.169),均 P > 0.05]。结论 内含子来源的 lncRNA SOS1⁃IT1 能够与宿主基因 SOS1竞争性结合细胞内源性 miR⁃124,通过竞争性内源 RNA(ceRNA)机制促进 SOS1的表达,并促进肝癌细胞的活性和DNA 复制。

关键词:

肝细胞癌; 长链非编码RNA RNA 竞争性内源RNA , 内含子

Abstract:

Objective To explore regulation of long non⁃coding RNA(lncRNA)SOS1⁃IT1 on hepatocellular carcinoma(HCC)cells and the underlying molecular mechanism. Methods Human HCC cell line QGY ⁃ 7703 was served as a cell model. CCK⁃8 assay was performed to detect cell viability,and EdU assay was applied to detect DNA replication activity. The potential miRNA binding sites(miRNA response elements,MREs)were predicted by bioinformatics analysis. The eukaryotic expression plasmid pcDNA3. 1(+)was used in ectopic expres⁃ sions of SOS1⁃IT1,SOS1⁃MRE and miR⁃124. The MREs were cloned into the downstream of an enhanced green fluorescent protein(EGFP)coding region to form fluorescent reporter plasmids. Fluorescent reporter gene assay was performed to detect the specific binding and regulation of miR⁃124 to the MREs. Results In human HCC cell line QGY⁃7703,overexpression of lncRNA SOS1⁃IT1 led to increase cell viability[(1.184 ± 0.114)vs.(0.928 ± 0.104),P < 0.05]and DNA replication[(0.625 ± 0.013)vs. 0.206 ± 0.016),P < 0.05],while suppression of SOS1⁃IT1 resulted in decreased cell viability[(0.648 ± 0.062)vs.(0.870 ± 0.091),P < 0.05]and DNA replication [(0.126 ± 0.022)vs. 0.271 ± 0.033,P < 0.05]. Bioinformatics analysis showed that SOS1 mRNA contained three and SOS1⁃IT1 contained one potential miR⁃124 reaction elements(MREs). Fluorescent reporter gene assay indicated that the first two MREs within SOS1 mRNA and the MRE within SOS1⁃IT1 were the functional binding sites of miR ⁃124. QGY ⁃7703 cells were transfected with the fluorescent reporter plasmid containing SOS1⁃MREs,alongwith SOS1⁃IT1⁃MRE expression plasmid,and an increase in fluorescent intensity was observed[(3.68 ± 0.315)vs. (2.71± 0.180),P < 0.05]. Further overexpression of miR⁃124 led to a fallback of the fluorescence intensity[(1.09 ± 0.143)vs.(4.04 ± 0.079),P < 0.05]. A change in fluorescence intensity did not occur if any of the MREs was mutated[(2.57 ± 0.244)vs.(2.71 ± 0.180)and(2.66 ± 0.20)vs.(2.88 ± 0.169),P > 0.05]. Conclusions lncRNA SOS1⁃ IT1 competitively binds endogenous miR ⁃124 with its host gene SOS1. SOS1⁃ IT1 promotes SOS1 expression and enhances HCC cell viability and DNA replication by the competing endogenous RNA(ceRNA)mechanism.

Key words:

hepatocellular carcinoma, long non ?coding RNA, microRNA, competing endogenous RNA, intron